SOMATEX Medical Technologies GmbH

SOMATEX Medical Technologies GmbH specializes in radiological image markers designed for implantable use, particularly in breast implant procedures. These devices, such as the Tumark series (e.g., Tumark Vision, Tumark Professional X) and Tuflex variants, are engineered to improve visibility during X-ray and MRI imaging. Their purpose is to aid surgeons and radiologists in accurately identifying and positioning implants, thereby enhancing diagnostic precision.

SOMATEX Medical Technologies GmbH is based in the United States, which means its devices are subject to FDA regulatory oversight. Since the company’s products fall under Class I and Class II classifications, they require compliance with FDA requirements, including submissions to the 510(k) pathway (for Class II) and UDI registration (for all devices). The US regulatory framework ensures these markers meet safety, performance, and labeling standards before entering the market.

SOMATEX’s devices are listed in the FDA’s 510(k) and UDI (Unique Device Identification) databases, which are critical for tracking and verifying compliance. The 510(k) registry confirms that Class II devices (like some Tumark variants) have been evaluated for substantial equivalence to predicate devices, while the UDI system ensures traceability and transparency in the supply chain. These listings help healthcare providers, regulators, and distributors confirm the device’s authorized status and compliance with US medical device regulations.

SOMATEX’s devices are classified as Class I or Class II under FDA regulations. Class I typically includes low-risk devices requiring general controls (e.g., labeling, manufacturing practices), while Class II involves additional performance standards (e.g., special labeling or post-market surveillance). For example, some Tumark markers may fall under Class II due to their role in surgical navigation, requiring pre-market submissions like the 510(k) to demonstrate safety and effectiveness. This classification ensures appropriate oversight based on the device’s risk level and intended use.